Order results by:
| Issue | Title | |
| Vol 5, No 3 (2013) | Thrombolytic therapy for ischemic stroke | Abstract similar documents |
| Natalia Vyacheslavovna Pizova | ||
| "... Systemic intravenous thrombolysis using recombinant tissue plasminogen activator (rt-PA ..." | ||
| Vol 4, No 4 (2012) | The mechanisms of reperfusion during in stroke patients treated with intravenous thrombolysis | Abstract similar documents |
| Maksim Alekseyevich Domashenko, M Yu Maksimova, M A Loskutnikov, A A Nikonov, V V Bryukhov, A S Suslin, M V Dreval, R N Konovalov | ||
| "... outcomes in patients treated with intravenous thrombolysis is reperfusion of an ischemic brain portion ..." | ||
| Vol 2, No 1 (2010) | EXPERIENCE IN USING INTRAVENOUS THROMBOLYSIS IN ISCHEMIC STROKE | Abstract similar documents |
| T. V. Demin, M. V. Saikhunov, D. R. Khasanova | ||
| "... The authors' experience leads to the conclusion that intravenous thrombolytic therapy (TLT ..." | ||
| Vol 17, No 1 (2025) | Thrombolytic therapy with Revelisa in ischemic stroke: results of the PRIMA international multicenter observational study | Abstract similar documents |
| N. A. Shamalov, D. R. Khasanova, S. V. Marchenko, M. A. Soldatov, T. P Alekseeva, O. V. Androfagina, L. N. Antipova, L. I. Anishchenko, E. M. Beketova, A. A. Bulanov, A. V. Gerasimova, N. Kh. Gorst, A. G. Gutsalyuk, T. V. Demin, A. V. Dyudin, U. A. Yelemanov, A. R. Zakaryaeva, N. N. Zinovyeva, S. S. Ziborova, D. N. Kazakov, N. V. Komissarova, I. V. Korobeynikov, K. V. Korovashkova, E. L. Kuzmin, A. A. Kulesh, R. R. Kuliev, A. S. Lebedev, A. L. Lukyanov, V. I. Maksimov, O. I. Mikhaylenko, I. V. Moldavskaya, D. M. Murtazalieva, Yu. S. Mukhamadieva, V. N. Nesterova, D. G. Novikov, S. V. Platunova, E. P. Prudius, R. A. Rayemgulov, V. A. Saskin, A. V. Sinelshchikova, E. A. Strautmanis, V. S. Suryakhin, E. V. Tavlueva, Yu. A. Telyatnik, N. V. Halo, M. S. Cherepyansky, N. A. Marskaya | ||
| "... and 565 (47.8%) men (mean age 68.28±12.56 years), of which 140 (11.9%) with staged reperfusion. The mean ..." | ||
| Vol 3, No 1 (2011) | Experience in using intravenous thrombolysis in ischemic stroke in Tatarstan | Abstract similar documents |
| D. R. Khasanova, T. V. Demin | ||
| "... The paper describes experience with intravenous thrombolysis used in a few vascular centers ..." | ||
| Vol 9, No 3 (2017) | Capabilities of perfusion ASPECTS in predicting the efficiency of intravenous thrombolytic therapy | Abstract PDF (Eng) similar documents |
| A. A. Kulesh, V. E. Drobakha, N. A. Kaileva, L. I. Syromyatnikova, Yu. A. Golosova, V. V. Shestakov | ||
| Vol 16, No 2 (2024) | The use of thromboaspiration and combined treatment in patients with ischemic stroke in real-life clinical practice | Abstract similar documents |
| T. V. Volchenkova, S. V. Kotov, E. V. Isakova, M. V. Sutormin, E. V. Patrin, B. B. Gegenava, M. N. Martynovich, I. G. Rudakova, L. V. Smetana, V. A. Borisova, S. V. Belkina | ||
| "... (intravenous thrombolysis with alteplase followed by aspiration thromboextraction), Group II underwent ..." | ||
| Vol 7, No 3 (2015) | Specific features of reperfusion therapy for vertebrobasilar ischemic stroke | Abstract similar documents |
| K. V. Anisimov, A. P. Tolmachev, Nikolai Anatolyevich Shamalov | ||
| "... in a shorter period of time and to use the advantages of both reperfusion techniques. Intravenous thrombolysis ..." | ||
| Vol 7, No 4 (2015) | Endovascular treatments for ischemic stroke: Present status and prospects | Abstract similar documents |
| A. V. Savello, D. V. Svistov, V. A. Sorokoumov | ||
| "... . Interventional treatments for IS should not be set off against intravenous thrombolytic therapy (ITT ..." | ||
| Vol 6, No 2S (2014): Special issue "Stroke" | Reperfusion therapy for ischemic stroke in the Russian Federation: Problems and promises | Abstract similar documents |
| N.A. Shamalov | ||
| "... involve highly effective brain substance reperfusion techniques (thrombolytic therapy (TLT)) aimed ..." | ||
| Vol 4, No 3 (2012) | Thrombolytic therapy in patients with ischemic stroke in the vertebrobasilar system | Abstract similar documents |
| K V Anisimov, A Yu Vishnyakova, G R Ramazanov, Nikolai Anatolyevich Shamalov, V G Lelyuk, V I Skvortsova | ||
| "... thrombolysis in verified ischemic stroke in the vertebrobasilar system (VBS), as well as the possibility ..." | ||
| Vol 6, No 3 (2014) | Factors influencing the efficiency and safety of systemic thrombolysis in patients with ischemic stroke | Abstract similar documents |
| N. A. Shamalov, K. V. Anisimov, M. A. Kustova, A. P. Tolmachev | ||
| "... Systemic thrombolysis using recombinant tissue plasminogen activator is the most effective ..." | ||
| Vol 7, No 1 (2015) | Possibility of predicting hemorrhagic transformation during reperfusion therapy for ischemic stroke in the patient population of the Sverdlovsk Region | Abstract similar documents |
| E. V. Prazdnichkova, A. M. Alasheev, A. A. Belkin, L. I. Volkova | ||
| "... systemic thrombolysis at the primary vascular departments of the Sverdlovsk Region in 2009 to 2013 were ..." | ||
| Vol 4, No 4 (2012) | Subtypes of ischemic cerebral circulation disorders at young age: diagnosis and treatment | Abstract similar documents |
| Natalia Vyacheslavovna Pizova | ||
| "... for IS. It is pointed out that the leading therapy option in these patients is thrombolysis; intravenous recombinant ..." | ||
| Vol 17, No 3 (2025) | Efficacy and safety of intravenous thrombolytic therapy in patients with ischemic stroke and mild neurological deficit | Abstract similar documents |
| M. R. Suleymanova, T. V. Danilova, D. R. Khasanova | ||
| "... Intravenous thrombolytic therapy (IV TLT) is the main method of reperfusion therapy for ischemic ..." | ||
| Vol 12, No 2 (2020) | Patent foramen ovale-related stroke: diagnostic approaches and the possibility of endovascular prophylaxis (clinical cases and literature review) | Abstract similar documents |
| A. A. Kulesh, D. V. Ognerubov, S. A. Mekhryakov, E. V. Merkulov, L. I. Syromyatnikova, A. S. Tereshchenko, A. N. Samko, V. V. Shestakov, Yu. V. Karakulova | ||
| "... underwent intravenous thrombolysis; control brain MRI revealed a right parietal lobe stroke. Standard ..." | ||
| Vol 3, No 4 (2011) | New possibilities of neuroprotection in ischemic stroke | Abstract similar documents |
| D. V. Sergeyev, M. A. Piradov, M. Yu. Maksimova, M. A. Domashenko, A. N. Sergeyeva, F. R. Okhtova | ||
| "... Reperfusion and neuroprotection are two present-day therapy strategies for patients with acute ..." | ||
| Vol 6, No 1S (2014): Special issue "Epilepsy" | Intravenous Antiepileptic Drugs in Russia | Abstract similar documents |
| P. N. Vlasov | ||
| "... Launching four intravenous antiepileptic drugs: valproate (Depakene and Convulex), lacosamide ..." | ||
| Vol 3, No 3 (2011) | Reperfusion therapy for ischemic stroke | similar documents |
| N. A. Shamalov, G. R. Ramazanov, K. V. Anisimov, V. I. Skvortsova | ||
| Vol 10, No 3 (2018) | Current strategies to improve the efficiency and safety of prevention and treatment of embolic stroke in non-valvular atrial fibrillation: possibilities of neutralizing therapy | Abstract similar documents |
| S. N. Yanishevsky | ||
| "... The paper reviews an update on the status of neurological care and thrombolysis in patients ..." | ||
| Vol 5, No 3 (2013) | Analysis of factors influencing the early efficiency of systemic thrombolytic therapy for ischemic stroke | Abstract similar documents |
| Elena Vladimirovna Prazdnichkova, A M Alasheev, O A Shalagina, L I Volkova | ||
| "... % of the patients, respectively. The interval between the onset of the disease onset and thrombolysis averaged 187 ..." | ||
| Vol 13, No 4 (2021) | Neuroprotective therapy in acute ischemic stroke | Abstract similar documents |
| A. A. Kulesh | ||
| "... in the era of active introduction of reperfusion treatment methods. The main mechanisms of brain damage ..." | ||
| Vol 4, No 1S (2012): Special issue "Epilepsy" | Efficacy and tolerance of intravenous lacosamide in urgent neurological situations | Abstract similar documents |
| P. N. Vlasov, E. G. Kamelkova, F. R. Drozzhina | ||
| "... The authors analyze the efficacy of intravenous lacosamide (LCSM) in combined therapy for partial ..." | ||
| Vol 6, No 2 (2014) | Heart diseases and strokes in young people | Abstract similar documents |
| N.V. Pizova | ||
| "... ischemic stroke is stated to include two procedures: reperfusion and neuronal protection. ..." | ||
| Vol 2, No 1 (2010) | SOME ASPECTS OF THE DIAGNOSIS AND TREATMENT OF ISCHEMIC STROKE | Abstract similar documents |
| V. A. Parfenov | ||
| "... and disability rates in survivors. Not only can thrombolysis that is, unfortunately, accessible only in a small ..." | ||
| Vol 10, No 3 (2018) | Effect of mexidol on the efficiency of intravenous thrombolytic therapy for ischemic stroke during the therapeutic window | Abstract similar documents |
| K. S. Knni, T. V. Dyomin, L. B. Adeeva | ||
| "... Objective: to evaluate the effect of intravenous mexidol on the efficiency of intravenous ..." | ||
| Vol 16, No 2 (2024) | Transient global amnesia | Abstract similar documents |
| A. A. Kulesh, D. A. Demin, N. A. Kayleva, S. A. Mekhryakov, S. V. Krapivin | ||
| "... examination and clarification of the question of thrombolysis according to general principles. When taking ..." | ||
| Vol 17, No 3 (2025) | Predicting clinical outcomes in patients with ischemic stroke following successful thrombectomy: clinical, neuroradiological, and periprocedural predictors | Abstract similar documents |
| K. V. Anisimov, N. Kh. Gorst, A. B. Berdalin, A. V. Kostin, K. N. Zhuravlev, D. V. Skrypnik, N. A. Shamalov | ||
| "... and satisfactory functional recovery (mRS 0–3) following successful EVT (defined as achieving TICI 2b/3 reperfusion ..." | ||
| Vol 14, No 4 (2022) | A clinical case of mechanical recanalization of recurrent cerebral embolism in the hyperacute period of ischemic stroke with hemorrhagic transformation | Abstract similar documents |
| D. M. Murtazalieva, A. R. Zakaryaeva, M. V. Strutsenko, I. Y. Osipov, Z. S. Shogenov | ||
| "... . As reperfusion therapy, thrombectomy from the M1 segment of the left MCA and simultaneous stenting of the left ..." | ||
| Vol 16, No 1 (2024) | Cortisol as a cerebral cortex neurons apoptosis regulator in acute phase of ischemic stroke (clinical and pathological study) | Abstract PDF (Eng) similar documents |
| S. P. Sergeeva, A. A. Savin, P. F. Litvitsky, L. R. Gorbacheva, A. V. Lyundup, I. D. Breslavich, L. A. Savin | ||
| "... no infectious complications, allergic reactions or oncological diseases and who did not undergo thrombolysis ..." | ||
| Vol 1, No 1 (2009) | THE ACUTE PERIOD OF ISCHEMIC STROKE: DIAGNOSIS AND TREATMENT | Abstract similar documents |
| V. A. Parfenov | ||
| "... in a specialized unit, which substantially reduces mortality and disability. The intravenous injection of tissue ..." | ||
| Vol 14, No 4 (2022) | Neurological complications of infective endocarditis: 10 rules of patient management | Abstract similar documents |
| D. A. Demin, A. A. Kulesh, O. I. Vinogradov, V. V. Demetskaya, D. Y. Kozmin, S. T. Enginoev, E. V. Demina, E. V. Nikolaeva, E. I. Shaposhnikova, D. R. Stompel | ||
| "... the clinical diagnosis of endocarditis in patients with stroke, features of reperfusion therapy, approaches ..." | ||
| Vol 5, No 3 (2013) | Miller–Fisher syndrome | Abstract similar documents |
| Anna Vladimirovna Kraeva, A B Galunova, L I Volkova | ||
| "... regressed due to a plasmapheresis session and intravenous immunoglobulin injection. ..." | ||
| Vol 13, No 5 (2021) | Difficult issues in the management of patients with atrial fibrillation: a neurologist's point of view | Abstract PDF (Eng) similar documents |
| A. A. Kulesh | ||
| "... and senile age, reperfusion therapy, presence of hemorrhagic transformation, combined atherosclerosis ..." | ||
| Vol 14, No 6 (2022) | Issues of improving the management of patients with ischemic stroke on the background of atrial fibrillation | Abstract similar documents |
| A. A. Kulesh, D. A. Demin | ||
| "... and senile patients, after reperfusion therapy, with the development of hemorrhagic transformation ..." | ||
| Vol 17, No 3 (2025) | Switching from ocrelizumab to ofatumumab: key potential reasons based on real-world clinical practice | Abstract similar documents |
| A. N. Boyko, T. O. Simaniv, T. A. Prokopyeva, S. V. Petrov, M. V. Melnikov | ||
| "... necessitate switching from the better-known intravenous drug ocrelizumab to the subcutaneous agent ofatumumab ..." | ||
| Vol 6, No 1S (2014): Special issue "Epilepsy" | A Clinical Analysis of Two Cases of Refractory Status Epilepticus of Generalized Convulsive Seizures | Abstract similar documents |
| V. A. Karlov, I. A. Zhidkova, P. N. Vlasov, B. P. Gladov, O. A. Podgornaya, S. V. Ukhanova | ||
| "... and the possibilities for using intravenous forms of antiepileptic drugs in combination with general anesthetic drugs ..." | ||
| No 1S (2016): | Status epilepticus: Analysis of refractory cases | Abstract similar documents |
| B. P. Gladov, O. A. Podgornaya, P. N. Vlasov | ||
| "... electroencephalography monitoring. The investigators evaluated the efficiency of treatment regimens with intravenous ..." | ||
| Vol 1, No 3-4 (2009) | CITICOLIN IN THE TREATMENT OF STROKE AND VASCULAR COGNITIVE DISORDERS | Abstract similar documents |
| V. A. Parfenov | ||
| "... evidence for the efficacy of intravenous or oral citicolin used within the first 24 hours of ischemic ..." | ||
| Vol 5, No 2S (2013): Special issue "Stroke" | Organization of prehospital medical care for patients with cerebral stroke | Abstract similar documents |
| Nikolai Anatolyevich Shamalov, A M Sidorov, A L Lukyanov | ||
| "... – время от поступления до начала тромболизиса, или время «от двери до иглы» (door-to-nee-dle time ..." | ||
| Vol 12, No 5 (2020) | Endovascular treatment results in patients with large cerebral artery occlusions in a metropolis. Moscow Stroke Registry data over 2019 | Abstract PDF (Eng) similar documents |
| D. V. Skrypnik, K. V. Anisimov, A. Yu. Botsina, T. V. Kiseleva, S. P. Grachev, N. A. Shamalov, E. Yu. Vasilyeva, A. V. Shpektor | ||
| "... results were assessed using the Thrombolysis in Cerebral Infarction (TICI) scale. The clinical outcomes ..." | ||
| Vol 2, No 4 (2010) | Experience in using ceretone (choline alfoscerate) in brain concussion | Abstract similar documents |
| N. G. Voropay, O. B. Doronina, B. M. Doronin | ||
| "... sleepiness, anxiety, and bad mood. Thirty-nine patients received intravenous ceretone® in a dose of 1000 mg ..." | ||
| Vol 3, No 1 (2011) | Current aspects of the epidemiology and treatment of chronic brain ischemiain the presence of essential hypertension (results of the CALIPSO program) | Abstract similar documents |
| E. I. Chukanova | ||
| "... . The patients received dropwise intravenous Cavinton as infusions within the first week (25 mg on days 1 to 4 ..." | ||
| Vol 14, No 5 (2022) | Safety of Mexidol® (ethylmethylhydroxypyridine succinate) in adult patients of different age groups | Abstract similar documents |
| E. A. Ushkalova, S. K. Zyryanov, O. I. Butranova | ||
| "... , which assessed the efficacy and safety of sequential therapy with Mexidol®, a solution for intravenous ..." | ||
| No 1S (2016): | Partial epilepsies: Choice of antiepileptic drugs in adults in the outpatient setting | Abstract similar documents |
| P. N. Vlasov | ||
| "... chrono or Depakine chronosphere and its intravenous formulation, favorable pharmacokinetic ..." | ||
| Vol 6, No 1 (2014) | The use of neurocytoprotectors to improve rehabilitation of patients after cerebrovascular accident | Abstract similar documents |
| V.V. Kovalchuk | ||
| "... received intravenous infusion of Thiocetam at a dose of 30 ml for 14 days, then 1 tablet TID for 1 month ..." | ||
| Vol 7, No 1S (2015): Special issue "Epilepsy" | Use of valproates in women of childbearing age and pregnant women with epilepsy | Abstract similar documents |
| P. N. Vlasov | ||
| "... forms, including long-acting or intravenous formulatons, and favorable pharmacokinetic ..." | ||
| Vol 15, No 3 (2023) | Cefepime-induced encephalopathy | Abstract similar documents |
| T. N. Pushkar, P. N. Vlasov, A. I. Belyakova-Bodina, A. G. Broutian | ||
| "... with intravenous administration of an antiepileptic drug (levetiracetam) was negative. A day after the withdrawal ..." | ||
| Vol 13, No 4 (2021) | Anti-B-cell therapy in patients with neuromyelitis optica spectrum disorders | Abstract PDF (Eng) similar documents |
| S. V. Kotov, E. S. Novikova, A. S. Kotov | ||
| "... and 18 women) aged 20-51 years who received RTX in 2019-2021. The treatment protocol included intravenous ..." | ||
| Vol 12, No 1 (2020) | The efficacy and safety of ethyl methyl hydroxypyridine succinate used as part of sequential therapy in patients with chronic cerebral ischemia | Abstract similar documents |
| V. V. Burdakov, D. V. Krasnykh | ||
| "... and atherosclerosis, who received intravenous Mexidol® administered dropwise at a dose of 500 mg once a day for 14 ..." | ||
| Vol 11, No 1 (2019) | Experience with anti-B-cell therapy in the pathogenetic treatment of multiple sclerosis | Abstract PDF (Eng) similar documents |
| O. V. Boyko, S. V. Petrov, N. Yu. Lashch, M. R. Guseva, A. N. Boyko | ||
| "... in patients with SPMS. All the patients received a treatment cycle of 600-mg intravenous ocrelizumab ..." | ||
| Vol 10, No 1 (2018) | Treatment of vertigo in elderly patients with chronic cerebrovascular disease | Abstract similar documents |
| S. N. Duma | ||
| "... who took betahistine 48 mg/day, intravenous Mexidol® 5.0 ml for 10 days, then 375 mg tablets daily ..." | ||
| Vol 10, No 2 (2018) | Effect of mexidol on lipid-phospholipid profile changes in elderly patients with stroke | Abstract similar documents |
| Yu. V. Abramenko | ||
| "... , the modified Rankin scale, and the Barthel index before and during intravenous dropwise infusion of mexidol 500 ..." | ||
| Vol 7, No 3 (2015) | Pharmacoeconomic analysis of the use of first- and second-line drugs in the treatment of multiple sclerosis | Abstract similar documents |
| V. R. Mkrtchyan, L. V. Brylev, O. V. Davydova, A. V. Belyanin, I. A. Shpak, A. M. Sergeev | ||
| "... ), subcutaneous glatiramer acetate (copaxone, 20 mg), intravenous natalizumab (tyzabri, 300 mg), and oral ..." | ||
| Vol 5, No 3 (2013) | Diabetic peripheral neuropathy therapy-induced activation of humoral serotonin and endogenous neurotrophins | Abstract similar documents |
| Yuulia Vladimirovna Karakulova, N B Kaigorodova, E A Batueva | ||
| "... to normalize carbohydrate metabolism, 30 patients with DPN received actovegin in an intravenous, jetwise dose ..." | ||
| Vol 4, No 1S (2012): Special issue "Epilepsy" | Clinical and electroencephalographic polymorphism of malignant migrating partial seizures in infancy | Abstract similar documents |
| A. A. Kholin | ||
| "... and reduce seizure frequency in 3 cases of benzo-diazepine-resistant SE in MMPSI. Intravenous convulex ..." | ||
| Vol 13, No 1 (2021) | Role of pathogenetic therapy for diabetic polyneuropathy | Abstract similar documents |
| D. A. Iskra, V. V. Kovalchuk, E. R. Barantsevich | ||
| "... the patients used Berlithione: Group 1 received its intravenous doses of 600 mg for 14 days, then oral ones ..." | ||
| Vol 2, No 3 (2010) | Specific features of psychopathological manifestations in criminal clozapine intoxications | Abstract similar documents |
| D. G. Slyundin, A. S. Livanov, V. V. Anuchin, A. G. Merkin, I. G. Bobrinskaya, E. V. Gutova | ||
| "... in the therapy was the use of the antidote intravenous aminostigmine and galantamine bromide in a dose of 2-3 mg ..." | ||
| 1 - 58 of 58 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
